Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 0

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 20-F (Mark One)

| ☐  | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| Or |                                                                                                |
| ☒  | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934           |

For the fiscal year ended December 31, 2024 Or

| ☐  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934    |
| Or |                                                                                             |
| ☐  | SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

Date of event requiring this shell company report For the transition period from to Commission File Number: 001-31368 _______________________________ Sanofi (Exact name of registrant as specified in its charter) N/A (Translation of registrant’s name into English) France (Jurisdiction of incorporation or organization) 46 , avenue de la Grande Armée , 75017 Paris , France (Address of principal executive offices) ________________________ Roy Papatheodorou , Executive Vice President, General Counsel 46 , avenue de la Grande Armée , 75017 Paris , France . Tel: + 33 1 53 77 40 00 (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person) ________________________ Securities registered or to be registered pursuant to Section 12(b) of the Act:

| Title of each class:                                                                                | Trading Symbol | Name of each exchange on which registered: |
| American Depositary Shares, each representing one halfof one ordinary share, par value €2 per share | SNY            | NASDAQ Global Select Market                |
| Ordinary shares, par value €2 per share                                                             | *              | NASDAQ Global Select Market*               |

Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None The number of outstanding shares of each of the issuer’s classes of capital or common stock as of December 31, 2024 was: Ordinary shares :